{"count": 3, "results": [{"_id": "33575476", "pmid": 33575476, "pmcid": "PMC7851485", "title": "Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways", "journal": "Mol Ther Oncolytics", "authors": ["Guo L", "Cui J", "Wang H", "Medina R", "Zhang S", "Zhang X", "Zhuang Z", "Lin Y"], "date": "2020-11-20T00:00:00Z", "doi": "10.1016/j.omto.2020.11.004", "meta_date_publication": "2021 Mar 26", "meta_volume": "20", "meta_issue": "", "meta_pages": "119-131", "score": 50259.066, "text_hl": "...To evaluate whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could enhance the @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@cisplatin@@@-induced anti-proliferative effect in @<m>DISEASE_Meningioma</m> @DISEASE_MESH:D008579 @@@meningioma@@@ cells in vitro, we first evaluated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s anti-@<m>DISEASE_Meningioma</m> @DISEASE_MESH:D008579 @@@meningioma@@@ effect alone. ", "citations": {"NLM": "Guo L, Cui J, Wang H, Medina R, Zhang S, Zhang X, Zhuang Z, Lin Y. Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways Mol Ther Oncolytics. 2021 Mar 26;20():119-131. PMID: 33575476", "BibTeX": "@article{33575476, title={Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways}, author={Guo L and Cui J and Wang H and Medina R and Zhang S and Zhang X and Zhuang Z and Lin Y}, journal={Mol Ther Oncolytics}, volume={20}, pages={119-131}}"}}, {"_id": "34680039", "pmid": 34680039, "pmcid": "PMC8533555", "title": "Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus", "journal": "Biomolecules", "authors": ["Tseng CH"], "date": "2021-09-25T00:00:00Z", "doi": "10.3390/biom11101405", "meta_date_publication": "2021 Sep 25", "meta_volume": "11", "meta_issue": "10", "meta_pages": "", "score": 50251.633, "text_hl": "While comparing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ ever users to never users, a significantly (50%) lower risk was observed for both BBT and @<m>DISEASE_Meningioma</m> @DISEASE_MESH:D008579 @@@cerebral meningioma@@@. ", "citations": {"NLM": "Tseng CH. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus Biomolecules. 2021 Sep 25;11(10):. PMID: 34680039", "BibTeX": "@article{34680039, title={Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus}, author={Tseng CH}, journal={Biomolecules}, volume={11}, number={10}}"}}, {"_id": "28708856", "pmid": 28708856, "pmcid": "PMC5510861", "title": "Diabetes, use of metformin, and the risk of meningioma", "journal": "PLoS One", "authors": ["Seliger C", "Meier CR", "Becker C", "Jick SS", "Proescholdt M", "Bogdahn U", "Hau P", "Leitzmann MF"], "date": "2017-07-14T00:00:00Z", "doi": "10.1371/journal.pone.0181089", "meta_date_publication": "2017", "meta_volume": "12", "meta_issue": "7", "meta_pages": "e0181089", "score": 50074.293, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@, use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and the risk of @<m>DISEASE_Meningioma</m> @DISEASE_MESH:D008579 @@@meningioma@@@", "citations": {"NLM": "Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF. Diabetes, use of metformin, and the risk of meningioma PLoS One. 2017;12(7):e0181089. PMID: 28708856", "BibTeX": "@article{28708856, title={Diabetes, use of metformin, and the risk of meningioma}, author={Seliger C and Meier CR and Becker C and Jick SS and Proescholdt M and Bogdahn U and Hau P and Leitzmann MF}, journal={PLoS One}, volume={12}, number={7}, pages={e0181089}}"}}]}